Literature DB >> 23313831

Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III.

María Silvina Stietz1, María Soledad Ramírez, Elisabet Vilacoba, Adriana Karina Merkier, Adriana Sara Limansky, Daniela Centrón, Mariana Catalano.   

Abstract

As a way to contribute to the assessment of Acinetobacter baumannii clinical population structure, multi-locus sequence typing (MLST) was performed in a collection of 93 isolates from Buenos Aires (1983-2012) and Rosario (2006-2009) hospitals. Sequence types (STs) were achieved by Bartual (B) and Institut Pasteur (P) schemes. PFGE typing, antimicrobial susceptibility assays, and the amplification of the OXA carbapenemase genes most prevalent in our region, were also performed. e-Burst clustered the 25 STs(B) (15 novels) into 5 clonal complexes (CC) and 5 singletons, and grouped the 18 STs(P) (12 novels) into 3 CC and 4 singletons. Bartual scheme divided the CC79(P) into two groups. CC113(B)/CC79(P) prevailed in Buenos Aires at least in 1992-2009, being responsible for epidemic and for endemic infections and acquiring the XDR (extensively drug-resistant) pattern throughout the years. While, CC119(B)/CC79(P) was apparently present before the CC113(B)/CC79(P)domain. CC103(B)/CC15(P) was the second most prevalent CC. Interestingly, CC110(B)/ST25(P) apparently increased over the last years. Conversely, CC109(B)/CC1(P) (international clone I) predominated in Rosario, although the presence of CC113(B)/CC79(P), CC103(B)/CC15(P) and CC110(B)/ST25(P) was observed. Nineteen novel STs clustered in CC79(P), CC15(P), CC113(B), CC109(B) and CC103(B), suggesting their clonal expansion during persistence. PFGE typing proved transmission of strains intra- and inter-hospitals in each city. Except for one, all the recent isolates (2007-2012) harboured the blaOXA-23-like. All isolates were susceptible to colistin. Tigecycline MIC(90) was 1mg/L and the rifampicin MIC>512mg/l was found among isolates in three hospitals. In conclusion, the international clone II (CC92(B)/CC2(P)) was not found among our isolates. CC113(B)/CC79(P), CC103(B)/CC15(P), and ST25(P), suggested also as major components in the A. baumannii population together with the international clone I, were present in Buenos Aires and Rosario with different prevalence rate. Their recent isolates showed high distribution of the blaOXA-23-like as well as the XDR pattern.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313831     DOI: 10.1016/j.meegid.2012.12.020

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  24 in total

1.  Genetic information on OXA-23-producing Acinetobacter baumannii strain CCBH15815, belonging to ST730/ST783, isolated from Brazil.

Authors:  Thiago Pavoni Gomes Chagas; Ricardo Magrani Junqueira; Marise Dutra Asensi
Journal:  Braz J Microbiol       Date:  2019-05-27       Impact factor: 2.476

2.  Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.

Authors:  Natacha Martins; Libera Dalla-Costa; Aline Almeida Uehara; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Infect Genet Evol       Date:  2013-10-10       Impact factor: 3.342

3.  Spreading of AbaR-type genomic islands in multidrug resistance Acinetobacter baumannii strains belonging to different clonal complexes.

Authors:  María Soledad Ramírez; Elisabet Vilacoba; María Silvina Stietz; Andrea Karina Merkier; Paola Jeric; Adriana S Limansky; Carolina Márquez; Helia Bello; Mariana Catalano; Daniela Centrón
Journal:  Curr Microbiol       Date:  2013-02-09       Impact factor: 2.188

4.  Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates.

Authors:  Natacha Martins; Renata Cristina Picão; Sheila Adams-Sapper; Lee W Riley; Beatriz Meurer Moreira
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

5.  Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates.

Authors:  S Montaña; E Vilacoba; G M Traglia; M Almuzara; M Pennini; A Fernández; A Sucari; D Centrón; M S Ramírez
Journal:  Curr Microbiol       Date:  2015-05-05       Impact factor: 2.188

6.  Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.

Authors:  Lalena Wallace; Sean C Daugherty; Sushma Nagaraj; J Kristie Johnson; Anthony D Harris; David A Rasko
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  Outbreak of extensively drug-resistant Acinetobacter baumannii indigo-pigmented strains.

Authors:  Elisabet Vilacoba; Marisa Almuzara; Lucia Gulone; Rocio Rodriguez; Elida Pallone; Romina Bakai; Daniela Centrón; María Soledad Ramírez
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

8.  Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.

Authors:  Adriana Correa; Rosa Del Campo; Kevin Escandón-Vargas; Marcela Perenguez; Mercedes Rodríguez-Baños; Cristhian Hernández-Gómez; Christian Pallares; Federico Perez; Cesar A Arias; Rafael Cantón; María V Villegas
Journal:  Microb Drug Resist       Date:  2017-06-01       Impact factor: 3.431

Review 9.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  Preferential carriage of class 2 integrons in Acinetobacter baumannii CC113 and novel singletons.

Authors:  M S Ramírez; S Montaña; M Cassini; D Centrón
Journal:  Epidemiol Infect       Date:  2015-02-20       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.